All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity Article

Morita, Takeshi, Miyakawa, Kei, Jeremiah, Sundararaj Stanleyraj et al. (2021). All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity . Viruses, 13(8), 10.3390/v13081669

Open Access

cited authors

  • Morita, Takeshi; Miyakawa, Kei; Jeremiah, Sundararaj Stanleyraj; Yamaoka, Yutaro; Sada, Mitsuru; Kuniyoshi, Tomoko; Yang, Jinwei; Kimura, Hirokazu; Ryo, Akihide

sustainable development goals

authors

publication date

  • August 1, 2021

published in

keywords

  • 3CL protease
  • DESIGN
  • EXPRESSION
  • FDA-approved drug
  • INTERFERON
  • Life Sciences & Biomedicine
  • PROTEASE INHIBITORS
  • SARS-CoV-2
  • Science & Technology
  • Virology
  • all-trans retinoic acid
  • antiviral efficacy
  • high throughput screening

Digital Object Identifier (DOI)

volume

  • 13

issue

  • 8